Literature DB >> 12103436

Chimeric hepatitis A virus particles presenting a foreign epitope (HIV gp41) at their surface.

Francesca Beneduce1, Yuri Kusov, Matthias Klinger, Verena Gauss-Müller, Graziella Morace.   

Abstract

Hepatitis A virus (HAV) protein 2A has been demonstrated to be involved in virus morphogenesis and suggested to be located on the surface of the particle. To determine whether this protein can function as a target structure to harbor and expose foreign epitopes on HAV particles, a full-length HAV cDNA, containing a seven amino acid stretch of human immunodeficiency virus type 1 (HIV-1) envelope protein gp41, was constructed. Following vaccinia virus MVA-T7-mediated expression of the cDNA in COS7 and Huh-T7 cells, chimeric HAV particles, exposing the foreign epitope gp41 on their surface, were produced. These particles were found to be empty capsids (70S), as judged by immunospecific enzyme linked immunosorbent assay (ELISA) on sucrose gradient fractions and immunoelectron microscopy. The immunological detection of VP1-2A harboring the gp41 epitope of HIV suggests that the 2A domain of HAV is suitable to present foreign antigenic epitopes. Copyright 2002 Elsevier Science BV.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12103436     DOI: 10.1016/s0166-3542(02)00073-6

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  5 in total

1.  Construction, expression and immunogenicity of a novel anti-hypertension angiotensin II vaccine based on hepatitis A virus-like particle.

Authors:  Xia Ou; Lili Guo; Jinyuan Wu; Kai Mi; Na Yin; Guangming Zhang; Hongjun Li; Maosheng Sun
Journal:  Hum Vaccin Immunother       Date:  2013-02-14       Impact factor: 3.452

2.  Engineering Recombinant Reoviruses To Display gp41 Membrane-Proximal External-Region Epitopes from HIV-1.

Authors:  Karl W Boehme; Mine' Ikizler; Jason A Iskarpatyoti; J Denise Wetzel; Jordan Willis; James E Crowe; Celia C LaBranche; David C Montefiori; Gregory J Wilson; Terence S Dermody
Journal:  mSphere       Date:  2016-05-18       Impact factor: 4.389

3.  A Recombinant HAV Expressing a Neutralization Epitope of HEV Induces Immune Response against HAV and HEV in Mice.

Authors:  Kui Xiang; Yuri Kusov; Guan Ying; Wang Yan; Yi Shan; Wu Jinyuan; Yin Na; Zhou Yan; Li Hongjun; Sun Maosheng
Journal:  Viruses       Date:  2017-09-15       Impact factor: 5.048

4.  Hepatitis A virus (HAV) packaging size limit.

Authors:  Krishnamurthy Konduru; Siham M Nakamura; Gerardo G Kaplan
Journal:  Virol J       Date:  2009-11-18       Impact factor: 4.099

5.  Poly(A) binding protein, C-terminally truncated by the hepatitis A virus proteinase 3C, inhibits viral translation.

Authors:  Bo Zhang; Graziella Morace; Verena Gauss-Müller; Yuri Kusov
Journal:  Nucleic Acids Res       Date:  2007-08-28       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.